Stockscreener 앱 받기
113.48
0.44%
0.50
시장 영업 전:
113.48
전일 마감가:
$112.98
열려 있는:
$113.86
하루 거래량:
2.12M
Relative Volume:
0.95
시가총액:
$32.07B
수익:
$7.07B
순이익/손실:
$1.29B
주가수익비율:
25.02
EPS:
4.5355
순현금흐름:
$993.00M
1주 성능:
+1.55%
1개월 성능:
-6.19%
6개월 성능:
-8.03%
1년 성능:
-5.35%
1일 변동 폭
$113.27
$114.52
1주일 범위
$110.03
$116.40
52주 변동 폭
$96.43
$160.27
애질런트 테크놀로지스 Stock (A) Company Profile
명칭
Agilent Technologies Inc
전화
(408) 345-8886
주소
5301 STEVENS CREEK BLVD, SANTA CLARA, CA
Compare A vs TMO, DHR, IDXX, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
A
Agilent Technologies Inc
|
113.48 | 32.07B | 7.07B | 1.29B | 993.00M | 4.5355 |
TMO
Thermo Fisher Scientific Inc
|
488.85 | 181.60B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
188.05 | 133.08B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
573.29 | 45.65B | 4.30B | 1.06B | 1.04B | 13.08 |
WAT
Waters Corp
|
300.56 | 29.49B | 3.17B | 642.63M | 516.49M | 10.77 |
애질런트 테크놀로지스 Stock (A) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-20 | 개시 | HSBC Securities | Buy |
| 2026-01-05 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2025-12-15 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2025-12-09 | 개시 | Goldman | Buy |
| 2025-12-02 | 개시 | Morgan Stanley | Overweight |
| 2025-10-08 | 개시 | Rothschild & Co Redburn | Buy |
| 2025-10-08 | 업그레이드 | UBS | Neutral → Buy |
| 2025-02-10 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2024-08-28 | 개시 | Wells Fargo | Overweight |
| 2024-07-10 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-06-27 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2024-06-03 | 재개 | Jefferies | Hold |
| 2024-04-05 | 업그레이드 | Stifel | Hold → Buy |
| 2023-12-13 | 개시 | Wolfe Research | Outperform |
| 2023-12-12 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-11-17 | 다운그레이드 | UBS | Buy → Neutral |
| 2023-09-28 | 개시 | Bernstein | Mkt Perform |
| 2023-07-31 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2023-05-24 | 재확인 | Barclays | Equal Weight |
| 2023-05-24 | 재확인 | BofA Securities | Buy |
| 2023-05-24 | 재확인 | Citigroup | Neutral |
| 2023-05-24 | 재확인 | Credit Suisse | Outperform |
| 2023-05-24 | 재확인 | Evercore ISI | Outperform |
| 2023-05-24 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-24 | 재확인 | Robert W. Baird | Outperform |
| 2023-05-24 | 재확인 | SVB Securities | Outperform |
| 2023-05-24 | 재확인 | Stifel | Hold |
| 2023-05-24 | 재확인 | TD Cowen | Outperform |
| 2023-05-24 | 재확인 | Wells Fargo | Overweight |
| 2023-05-11 | 개시 | Barclays | Equal Weight |
| 2023-01-10 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-07-20 | 개시 | UBS | Buy |
| 2022-07-08 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-04-25 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-02-23 | 재확인 | BofA Securities | Buy |
| 2022-02-23 | 재확인 | Citigroup | Buy |
| 2022-02-23 | 재확인 | Cowen | Outperform |
| 2022-02-23 | 재확인 | Evercore ISI | Outperform |
| 2022-02-23 | 재확인 | Stifel | Hold |
| 2022-02-23 | 재확인 | Wells Fargo | Overweight |
| 2021-11-23 | 재확인 | BofA Securities | Buy |
| 2021-11-23 | 재확인 | Cowen | Outperform |
| 2021-11-23 | 재확인 | Stifel | Hold |
| 2021-03-18 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-02-17 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-12-02 | 개시 | Goldman | Buy |
| 2020-11-25 | 업그레이드 | UBS | Neutral → Buy |
| 2020-11-17 | 업그레이드 | Cleveland Research | Neutral → Buy |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-09-30 | 개시 | Atlantic Equities | Neutral |
| 2020-08-19 | 재확인 | BofA Securities | Neutral |
| 2020-08-19 | 재확인 | Citigroup | Neutral |
| 2020-08-19 | 재확인 | Jefferies | Buy |
| 2020-08-19 | 재확인 | Robert W. Baird | Outperform |
| 2020-08-19 | 재확인 | SVB Leerink | Outperform |
| 2020-08-19 | 재확인 | Stifel | Hold |
| 2020-08-19 | 재확인 | Wells Fargo | Overweight |
| 2020-02-24 | 다운그레이드 | Needham | Buy → Hold |
| 2020-01-08 | 개시 | Wells Fargo | Overweight |
| 2020-01-07 | 개시 | Citigroup | Neutral |
| 2019-11-26 | 재확인 | Needham | Buy |
| 2019-11-15 | 개시 | Stifel | Hold |
| 2019-10-18 | 다운그레이드 | UBS | Buy → Neutral |
| 2019-07-16 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-07-15 | 다운그레이드 | Barclays | Overweight → Equal Weight |
모두보기
애질런트 테크놀로지스 주식(A)의 최신 뉴스
Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Esophageal or Gastroesophageal Junction (GEJ) Carcinoma - BioSpace
Vanguard disaggregates holdings after realignment — Agilent (NYSE: A) - Stock Titan
Agilent Technologies (A) Gains FDA Approval for Diagnostic Tool in KEYTRUDA Treatment - GuruFocus
Agilent Technologies, Inc. Receives FDA Approval For PD-L1 IHC 22C3 PharmDx In Esophageal Or Gastroesophageal Junction Carcinoma - marketscreener.com
Agilent Technologies Inc. stock climbs on launch of advanced chromatography solutions boosting life - AD HOC NEWS
Agilent Technologies Inc. stock climbs amid new chromatography solutions launch signaling life scien - AD HOC NEWS
Agilent Technologies Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Aug Weekly: Will Agilent Technologies Inc benefit from current market trends2026 Big Picture & Momentum Based Trading Signals - baoquankhu1.vn
Pensionfund Sabic Buys New Position in Agilent Technologies, Inc. $A - MarketBeat
Agilent Technologies, Inc. (A) latest stock news and headlines - Yahoo Finance Singapore
Agilent Technologies Inc. stock rises on advanced chromatography solutions launch boosting lab effic - AD HOC NEWS
Agilent Technologies Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Agilent Technologies Inc. stock rises on advanced chromatography solutions launch boosting life scie - AD HOC NEWS
Bullish Move: Sue Rataj Shows Confidence, Acquires $241K In Agilent Technologies Stock - Benzinga
Agilent Technologies (A) to Acquire Biocare Medical for $950M - Insider Monkey
Agilent Technologies Faces Mixed Technical Signals Amid Valuation Adjustments - Markets Mojo
SG Americas Securities LLC Has $109.97 Million Position in Agilent Technologies, Inc. $A - MarketBeat
A SEC FilingsAgilent Technologies Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Agilent Q1 earnings miss estimates, revenues up Y/Y, shares fall - MSN
Agilent Technologies (A) Announces Amendments to Corporate Gover - GuruFocus
Agilent Technologies | 4: Statement of changes in beneficial ownership of securities-Director Soriot Pascal - Moomoo
Agilent, Axion End Cell Analysis IP Suit After Jury Selection - Law360
Agilent Technologies Launches Advanced Chromatography Solutions Enhancing Precision in Drug Developm - AD HOC NEWS
Agilent (NYSE: A) director granted 2,158 fully vested common shares - Stock Titan
Agilent (NYSE: A) director Otis Brawley granted vested stock awards - Stock Titan
Director George Scangos gets 3,215 Agilent (NYSE: A) shares - Stock Titan
Director at Agilent (NYSE: A) gets stock grant, surrenders shares for tax - Stock Titan
Agilent (NYSE: A) director Wilson Dow reports fully vested stock grant - Stock Titan
Agilent (NYSE: A) director receives 2,158-share stock award, defers receipt - Stock Titan
Agilent Technologies | 4: Statement of changes in beneficial ownership of securities-Director KOH BOON HWEE - Moomoo
Agilent (NYSE: A) director granted shares and withholds stock for taxes - Stock Titan
Agilent (NYSE: A) director granted 2,158 fully vested shares, holds 7,138 - Stock Titan
Agilent (NYSE: A) director Judy Brown granted 2,158 fully vested shares - Stock Titan
Agilent (NYSE: A) director Mala Anand granted 2,158 fully vested shares - Stock Titan
Agilent, Axion Nix Patent Trial, Pause Cases as They Near Deal - Bloomberg Law News
Agilent Technologies, Inc. (A) Stock Price, News, Quote & History - Yahoo Finance
Nordea Investment Management AB Sells 106,321 Shares of Agilent Technologies, Inc. $A - MarketBeat
Agilent Technologies Advances Chromatography Innovations for Pharma and Biotech Efficiency in 2026 - AD HOC NEWS
Agilent Technologies Advances Chromatography Innovations for Pharma and Biotech in 2026 - AD HOC NEWS
Agilent, Danaher could be potential buyers of Qiagenanalyst - MSN
Agilent Technologies Powers Art Conservation Workshop at Yale University - Yahoo
Agilent’s USCAP 2026 Pathology Updates Deepen Oncology Diagnostics Narrative - Sahm
Dividend Watch: Whats the beta of Agilent Technologies Inc stockMarket Sentiment Review & Reliable Entry Point Alerts - baoquankhu1.vn
Agilent Shareholders Approve Board Declassification and Governance Changes - TipRanks
Agilent (NYSE: A) holders back board declassification and pay votes - Stock Titan
Agilent Debuts Future of the Automated Laboratory at Korea Lab 2026 - marketscreener.com
AIA Group Ltd Invests $2.48 Million in Agilent Technologies, Inc. $A - MarketBeat
Aug PostEarnings: Is Agilent Technologies Inc showing insider buyingQuarterly Portfolio Summary & Verified Trade Idea Suggestions - baoquankhu1.vn
Agilent Showcases Advances in Precision Oncology and Digital Pathology at USCAP 2026 - BioSpace
Agilent G4513A Injector Tower Drives GC/MS Precision in Latest LabRulez 2026 Applications - AD HOC NEWS
Danske Bank A S Takes $51.53 Million Position in Agilent Technologies, Inc. $A - MarketBeat
애질런트 테크놀로지스 (A) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.58%
2.27%
자본화:
|
볼륨(24시간):